Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs

Calreticulin (CALR), an endoplasmic reticulum–associated chaperone, is frequently mutated in myeloproliferative neoplasms (MPNs). Mutated CALR promotes downstream JAK2/STAT5 signaling through interaction with, and activation of, the thrombopoietin receptor (MPL). Here, we provide evidence of a novel...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood Adv
Egile Nagusiak: Balliu, Manjola, Calabresi, Laura, Bartalucci, Niccolò, Romagnoli, Simone, Maggi, Laura, Manfredini, Rossella, Lulli, Matteo, Guglielmelli, Paola, Vannucchi, Alessandro Maria
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2021
Gaiak:
Myeloid Neoplasia
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8095134/
https://ncbi.nlm.nih.gov/pubmed/33890979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003291
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak